Percutaneous sclerotherapy of a giant mediastinal lymphangioma.

Abstract

The present study reports a case of percutaneous sclerotherapy of a giant mediastinal cystic lymphangioma using Ethibloc (Ethicon, Norderstedt, Germany) and absolute ethanol in a 59-yr-old female. The tumour, situated predominantly in a retrocardiac location, caused dyspnoea and dysphagia by compression and was considered unresectable. Follow-up computed tomography 3 yrs after treatment showed a 90% volume reduction of the tumour. The patient is currently asymptomatic. To the best of the present authors' knowledge, percutaneous transthoracic sclerotherapy of a mediastinal lymphangioma has not previously been reported in the literature available in English.

• Authors: A Desir, B Ghaye, B Duysinx, R F Dondelinger
• Journal: The European respiratory journal (Eur Respir J) Vol. 32 Issue 3 Pg. 804-6 (Sep 2008) ISSN: 1399-3003 [Electronic] England
• PMID: 18757704 (Publication Type: Case Reports, Journal Article)

Chemical References

• Drug Combinations
• Fatty Acids
• Propylene Glycols
• Sclerosing Solutions
• Diatrizoate
• Zein
• alcoholic prolamine solution

Topics

• Diatrizoate (therapeutic use)
• Drug Combinations
• Fatty Acids (therapeutic use)
• Female
• Humans
• Lymphangioma, Cystic (pathology, therapy)
• Magnetic Resonance Imaging
• Mediastinal Neoplasms (pathology, therapy)
• Middle Aged
• Propylene Glycols (therapeutic use)
• Sclerosing Solutions (therapeutic use)
• Sclerotherapy
• Tomography, Spiral Computed
• Zein (therapeutic use)